JP2016527186A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527186A5
JP2016527186A5 JP2016514479A JP2016514479A JP2016527186A5 JP 2016527186 A5 JP2016527186 A5 JP 2016527186A5 JP 2016514479 A JP2016514479 A JP 2016514479A JP 2016514479 A JP2016514479 A JP 2016514479A JP 2016527186 A5 JP2016527186 A5 JP 2016527186A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
independently
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016514479A
Other languages
English (en)
Japanese (ja)
Other versions
JP6643758B2 (ja
JP2016527186A (ja
Filing date
Publication date
Priority claimed from GB201309248A external-priority patent/GB201309248D0/en
Priority claimed from GB201404301A external-priority patent/GB201404301D0/en
Application filed filed Critical
Priority claimed from PCT/GB2014/051547 external-priority patent/WO2014188178A1/en
Publication of JP2016527186A publication Critical patent/JP2016527186A/ja
Publication of JP2016527186A5 publication Critical patent/JP2016527186A5/ja
Application granted granted Critical
Publication of JP6643758B2 publication Critical patent/JP6643758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016514479A 2013-05-22 2014-05-21 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用 Active JP6643758B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201309248A GB201309248D0 (en) 2013-05-22 2013-05-22 Compounds and combinations
GB1309248.1 2013-05-22
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations
GB1404301.2 2014-03-11
PCT/GB2014/051547 WO2014188178A1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics

Publications (3)

Publication Number Publication Date
JP2016527186A JP2016527186A (ja) 2016-09-08
JP2016527186A5 true JP2016527186A5 (enExample) 2017-07-20
JP6643758B2 JP6643758B2 (ja) 2020-02-12

Family

ID=50829204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514479A Active JP6643758B2 (ja) 2013-05-22 2014-05-21 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用

Country Status (19)

Country Link
US (1) US10407467B2 (enExample)
EP (1) EP2999711B1 (enExample)
JP (1) JP6643758B2 (enExample)
KR (1) KR102354902B1 (enExample)
CN (1) CN105308065B (enExample)
BR (1) BR112015029309A2 (enExample)
CA (1) CA2939061C (enExample)
DK (1) DK2999711T3 (enExample)
ES (1) ES2923762T3 (enExample)
HR (1) HRP20220898T1 (enExample)
HU (1) HUE059544T2 (enExample)
LT (1) LT2999711T (enExample)
PL (1) PL2999711T3 (enExample)
PT (1) PT2999711T (enExample)
RS (1) RS63484B1 (enExample)
RU (1) RU2730012C2 (enExample)
SI (1) SI2999711T1 (enExample)
TW (1) TWI665218B (enExample)
WO (1) WO2014188178A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX355217B (es) * 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
RU2730012C2 (ru) 2013-05-22 2020-08-14 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
EP3038615A4 (en) * 2013-08-28 2017-04-12 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
SI3116897T1 (sl) * 2014-03-11 2022-06-30 Spero Therapeutics, Inc. Derivati polimiksina in njihova uporaba v kombinacijskem zdravljenju skupaj z različnimi antibiotiki
EP3224273A1 (en) 2014-11-26 2017-10-04 New Pharma Licence Holdings Limited Compounds
CN107257803B (zh) * 2014-12-16 2021-02-05 上海盟科药业股份有限公司 用于治疗细菌感染的多粘菌素类抗菌剂
FI126143B (en) 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
KR101790296B1 (ko) * 2015-03-26 2017-10-26 한국생명공학연구원 네트롭신을 유효성분으로 포함하는 그람음성 세균에 대한 폴리믹신의 항균 활성을 증가시키는 조성물
WO2016166103A1 (en) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
JP7367950B2 (ja) * 2015-09-29 2023-10-24 モナッシュ ユニバーシティ 抗菌性ポリミキシン誘導体化合物
CN109789125B (zh) * 2016-08-16 2022-10-18 罗切斯特大学 含有基于多粘菌素b/甲氧苄啶的治疗剂的药物组合物
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
US11191773B2 (en) 2017-07-17 2021-12-07 President And Fellows Of Harvard College Methods of treatment for bacterial infections
WO2019085926A1 (zh) * 2017-10-31 2019-05-09 上海医药工业研究院 多黏菌素类似物及其制备方法
EP3704135A4 (en) 2017-11-02 2022-04-27 The University of Queensland PEPTIDE ANTIBIOTICS
WO2019178119A1 (en) 2018-03-12 2019-09-19 President And Fellows Of Harvard College Aminocoumarin compounds and methods of their use
TWI851584B (zh) 2018-06-25 2024-08-11 新加坡商雲頂新耀股份有限公司 化合物
CN111690040A (zh) * 2019-03-12 2020-09-22 上海来益生物药物研究开发中心有限责任公司 多粘菌素衍生物、其制备方法和应用
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
CN115298198A (zh) 2020-01-21 2022-11-04 上海盟科药业股份有限公司 用于肾相关癌症靶向治疗的新型化合物和组合物
US12472195B2 (en) 2020-07-02 2025-11-18 Purdue Research Foundation Inhalation formulations of antimicrobial compounds
WO2022098950A1 (en) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Compounds
EP4289272A4 (en) * 2021-02-02 2024-07-17 Korea Research Institute of Bioscience and Biotechnology ANTIMICROBIAL ADJUVANT WITH BIPHENYL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT AND USES THEREOF
EP4366831A4 (en) 2021-07-09 2025-06-11 Aligos Therapeutics, Inc. ANTI-VIRAL COMPOUNDS
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds
WO2024003042A1 (en) 2022-06-28 2024-01-04 Breakthrough Biotech Drift Aps Novel combinations of sesquiterpene alcohols, polymyxins and nisin compounds as antimicobial and/or antifungal compounds
WO2024105689A1 (en) * 2022-11-14 2024-05-23 Cipla Limited Novel ophthalmic composition
WO2025030169A2 (en) * 2023-08-03 2025-02-06 Arcum Vision Inc. Enhanced formulation of polymyxin b/ trimethoprim and rifampin and methods for ophthalmic uses
KR20250037611A (ko) * 2023-09-07 2025-03-18 웰펩 주식회사 그람 음성균 및 다제내성 그람 음성균에 우수한 항균 활성을 갖는 신규 폴리믹신 유사체, 이를 포함하는 항균용 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
WO1988000950A2 (fr) 1986-08-06 1988-02-11 Fauchere Jean Luc Fabrication de conjugues a liaisons de covalence a partir d'un antibiotique et d'un derive non toxique de la polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (enExample) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
JP4583559B2 (ja) * 2000-07-24 2010-11-17 栄研化学株式会社 Mrsaスクリーニング用培地
WO2005032470A2 (en) 2003-09-30 2005-04-14 Kohi Corporation Compositions and methods for treating burns
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2008001773A1 (fr) 2006-06-27 2008-01-03 Toyo Tire & Rubber Co., Ltd. pneu apte à rouler dégonflé
BRPI0715095B8 (pt) * 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
NZ593892A (en) 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
JP5493387B2 (ja) * 2009-02-25 2014-05-14 国立大学法人 東京大学 選択培地の製造方法及びその利用
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
US9226786B2 (en) * 2011-03-22 2016-01-05 Lexion Medical Llc Medical devices for clearing a surgical site
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
MX355217B (es) * 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
RU2730012C2 (ru) 2013-05-22 2020-08-14 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
WO2015149131A1 (en) 2014-04-01 2015-10-08 Monash University Polymyxin derivatives as antimicrobial compounds

Similar Documents

Publication Publication Date Title
JP2016527186A5 (enExample)
RU2015148032A (ru) Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
US12161690B2 (en) Glycopeptide compositions
AU2022383265A1 (en) Bcma monoclonal antibody and the antibody-drug conjugate
RU2013144368A (ru) Пролекарства действующих веществ гетероциклическими линкерами
RU2017144859A (ru) Конъюгаты сконструированных антител с цистеиновыми заменами
JP2012512898A (ja) ジペプチド結合薬用剤
RU2010106877A (ru) Дипептидные пролекарства и их применение
JP2013533864A5 (enExample)
RU2014131370A (ru) Терапевтические соединения, содержащие бор
DD158238A5 (de) Verfahren zur herstellung eines neuen inhibitors fuer das angiotensin umwandelnde enzym
EP1878429B1 (en) Trenadermal absorption preparation
WO2011038066A4 (en) Novel npr-b agonists
EP3823630A1 (en) Peptides for activation of cell signaling in osteoprogenitor cells
WO2012031228A2 (en) Llp2a-bisphosphonate conjugates for osteoporosis treatment
KR20220041152A (ko) 뼈-결합 화합물
CN1633300A (zh) 透皮制剂
RU2013102588A (ru) Новые октапептидные соединения и их терапевтическое применение
US20250064955A1 (en) Drug conjugates and methods of preparing and using the same
WO2000027374B1 (en) The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury
CN109476704B (zh) 抗菌环脂肽
EP4304721A1 (en) Stapled antimicrobial peptides (stamps) and uses thereof
JPWO2023275357A5 (enExample)